Share on StockTwits

Shares of Covidien plc (NYSE:COV) have earned a consensus recommendation of “Buy” from the eighteen analysts that are currently covering the company, AnalystRatingsNetwork reports. Two analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $76.60.

COV has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Covidien plc in a research note on Tuesday, April 1st. They now have a $77.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of Covidien plc from $74.00 to $79.00 in a research note on Thursday, March 27th. Finally, analysts at BTIG Research initiated coverage on shares of Covidien plc in a research note on Tuesday, March 11th. They set a “buy” rating on the stock.

Covidien plc (NYSE:COV) traded up 0.04% on Tuesday, hitting $70.70. 317,592 shares of the company’s stock traded hands. Covidien plc has a 52-week low of $53.0496 and a 52-week high of $73.77. The stock has a 50-day moving average of $71.0 and a 200-day moving average of $67.85. The company has a market cap of $31.868 billion and a P/E ratio of 20.53.

Covidien plc (NYSE:COV) last released its earnings data on Friday, January 24th. The company reported $1.00 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.94 by $0.06. The company had revenue of $2.64 billion for the quarter, compared to the consensus estimate of $2.61 billion. During the same quarter last year, the company posted $0.97 earnings per share. Covidien plc’s revenue was down 13.6% compared to the same quarter last year. On average, analysts predict that Covidien plc will post $4.02 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Monday, May 5th. Investors of record on Monday, April 7th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 1.81%. The ex-dividend date is Thursday, April 3rd.

Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.